Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 5 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Neurovascular abnormalities in retinopathy of prematurity and emerging therapies.
J Mol Med (Berl). 2022 Jun;100(6):817-828. doi: 10.1007/s00109-022-02195-2. Epub 2022 Apr 8.
J Mol Med (Berl). 2022.
PMID: 35394143
Free PMC article.
Review.
Profiling disease-selective drug targets: From proteomics to ligandomics.
Waduge P, Tian H, Webster KA, Li W.
Waduge P, et al.
Drug Discov Today. 2023 Mar;28(3):103430. doi: 10.1016/j.drudis.2022.103430. Epub 2022 Nov 4.
Drug Discov Today. 2023.
PMID: 36343915
Free PMC article.
Review.
Item in Clipboard
Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization.
Ji L, Waduge P, Hao L, Kaur A, Wan W, Wu Y, Tian H, Zhang J, Webster KA, Li W.
Ji L, et al.
FASEB J. 2022 Jan;36(1):e22106. doi: 10.1096/fj.202101085RR.
FASEB J. 2022.
PMID: 34918375
Free PMC article.
Item in Clipboard
Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy.
Dai C, Tian H, Bhatt A, Su G, Webster KA, Li W.
Dai C, et al.
Front Biosci (Landmark Ed). 2022 Apr 19;27(4):130. doi: 10.31083/j.fbl2704130.
Front Biosci (Landmark Ed). 2022.
PMID: 35468689
Free PMC article.
Item in Clipboard
Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy.
He Y, Tian H, Dai C, Wen R, Li X, Webster KA, Li W.
He Y, et al.
Int J Mol Sci. 2021 Dec 29;23(1):350. doi: 10.3390/ijms23010350.
Int J Mol Sci. 2021.
PMID: 35008775
Free PMC article.
Item in Clipboard
Comparative ligandomics implicates secretogranin III as a disease-restricted angiogenic factor in laser-induced choroidal neovascularization.
Ji L, Waduge P, Wan W, Tian H, Li J, Zhang J, Chen R, Li W.
Ji L, et al.
FEBS J. 2022 Jun;289(12):3521-3534. doi: 10.1111/febs.16356. Epub 2022 Feb 1.
FEBS J. 2022.
PMID: 35038348
Free PMC article.
Item in Clipboard
Cite
Cite